Mayne Pharma GroupMYX 
$3.132.89%24h
2.89%24h
Global rank15467
Market cap$257.41M
Change 7d-4.34%
YTD Performance-24.72%
SP500 benchmarkUnderperform
P/E0
P/S2.09
Revenue$123.39M
Earnings$79.26M
Dividend yield-
Main Sector
Healthcare
Category
Mayne Pharma Group (MYX) Cash on Hand
MYX Cash on Hand in 2022: $148.93M
According to Mayne Pharma Group latest financial reports the cash on hand of MYX is $148.93M, an increase of 127.72% to 2022. At the end of 2022 company had $65.40M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
MYX Cash on Hand History from 2019 to 2023
-
Value:-
MYX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $148.93M | 127.72% |
| 2022 | $65.40M | -1.33% |
| 2021 | $66.29M | -28.89% |
| 2020 | $93.22M | 54.81% |
| 2019 | $60.21M | - |
View the Top Cash on Hand Companies 
